Medical Devices

Valitor's VLTR-559 shows superior durability in preclinical data, potentially slashing wet AMD treatment from monthly injections to just two per year.

A strategic acquisition brings a top impairment expert's training under a leading online platform, set to redefine workers' compensation professional development.

A landmark partnership between Propella Group and TISTR aims to unlock Thailand's hidden scientific gems, creating a pipeline for global VCs.

With its Juveena hydrogel pending FDA approval, Rejoni brings in a commercialization expert to tackle the underserved market for intrauterine adhesions.

An ultra-rare disease affects thousands, but few are diagnosed. Now, a new alliance of industry and advocates is racing to solve the diagnostic puzzle.

With backing from Eli Lilly, Cabaletta Bio's $150M financing will accelerate its potentially curative cell therapies for autoimmune diseases.

GRIN Therapeutics expands its pivotal Phase 3 study for radiprodil to Europe, fueling hope for a first-ever targeted therapy for a rare neurological disorder.

Spanish CDMO ROIS acquires a major Phoenix facility from Bristol Myers Squibb, securing US drug supply chains and expanding its global footprint.

New FDA clearance for Hepatoscope adds spleen exams and industry-first compliance, changing how clinicians manage liver disease at the point of care.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

The medical device manufacturer appoints the former Corza Medical CEO to manage its rapid expansion and solidify its leadership in a competitive global market.

Pivotal trial results for a 3D-printed surgical guide show a dramatic drop in follow-up surgeries, heralding a new era of precision for patients.

As demand for complex medical flights soars, a specialized industry of 'flying ICUs' navigates immense logistical and medical hurdles to save lives.

Former Gov. Larry Hogan, a cancer survivor, joins the board of radiology giant RP, blending public health policy with a push for AI-driven diagnostics.

TaeWoong Medical USA's new FDA-cleared SPAXUS stent offers a safer, minimally invasive option for complex pancreatic and gallbladder drainage procedures.

With new FDA clearance, Zeta Surgical's portable AI navigation system could bring millimeter-precision brain surgery to any hospital, not just elite centers.

A new software-only approach from Retia Medical promises to turn routine monitors into powerful cardiac tools, democratizing critical care without new hardware.

Amid record growth, the supply platform adds top advisors Oliver Gelles and Dr. Anil Idiculla and prepares to launch a new AI invoice verification tool.

A new partnership brings the Aplio i800 EUS to the U.S., offering advanced imaging to improve early, less invasive diagnosis of complex GI conditions.

Medcura adds a Johnson & Johnson heavyweight to its board, aiming to disrupt the surgical hemostasis market with its FDA-designated breakthrough gel, LifeGel.